Investment Group to Invest up to $35M into Accelr8; New CEO Tapped | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accelr8 today announced an investment group plans to invest up to $35 million into the company to support further development and commercialization of its BACcel platform.

In conjunction with the investment, one member of the investment group will become Accelr8's CEO.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.